Orion Pharma Limited (DSE:ORIONPHARM)

Market Cap	7.37B
Revenue (ttm)	6.19B
Net Income (ttm)	-109.39M
Shares Out	234.00M
EPS (ttm)	-0.47
PE Ratio	n/a
Forward PE	n/a
Dividend	1.00 (3.17%)
Ex-Dividend Date	Dec 5, 2024

Volume	542,418
Average Volume	498,280
Open	30.70
Previous Close	30.50
Day's Range	30.60 - 32.00
52-Week Range	25.20 - 59.70
Beta	-0.57
RSI	51.02
Earnings Date	Nov 16, 2025

About Orion Pharma

Orion Pharma Limited engages in the creation, discovery, development, manufacturing, and marketing of pharmaceutical products in Bangladesh. The company produces products in various dosage forms, including tablets, capsules, syrups, suspensions, injections, and dry powder for syrup/ suspension in various therapeutic groups, such as anticancer, antibiotics, anti-diabetics, anxiolytics, diuretics, cardiovascular drugs, etc. It also provides various vaccines and health-related consumer products, as well as generates and supplies electricity. The c...

• Industry: Pharmaceutical Preparations
• Founded: 1965
• Employees: 3,160
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: ORIONPHARM

Financial Performance

In 2024, Orion Pharma's revenue was 10.62 billion, a decrease of -23.74% compared to the previous year's 13.93 billion. Earnings were 318.12 million, a decrease of -50.37%.